GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Total Stockholders Equity

Nuvation Bio (Nuvation Bio) Total Stockholders Equity : $769.37 Mil (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Total Stockholders Equity?

Nuvation Bio's Total Stockholders Equity for the quarter that ended in Sep. 2021 was $769.37 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Nuvation Bio's Book Value per Share for the quarter that ended in Sep. 2021 was $N/A. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Nuvation Bio's Debt-to-Equity for the quarter that ended in Sep. 2021 was 0.00.

Nuvation Bio Total Stockholders Equity Historical Data

The historical data trend for Nuvation Bio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Total Stockholders Equity Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Total Stockholders Equity
119.30 746.00

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Total Stockholders Equity Get a 7-Day Free Trial 119.30 806.34 788.94 769.37 746.00

Nuvation Bio  (NYSE:NUVB.WS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Nuvation Bio's Book Value per Share for the quarter that ended in Sep. 2021 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(769.366-0)/0
=N/A

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Nuvation Bio's Debt-to-Equity for the quarter that ended in Sep. 2021 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 769.366
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nuvation Bio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Nuvation Bio (Nuvation Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Total Stockholders Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Website
https://www.nuvationbio.com
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.